Have a personal or library account? Click to login
Response Rate in CLL Patients Treated with Obinutuzumab - Single Centre Experience from University Clinic of Hematology, Skopje Cover

Response Rate in CLL Patients Treated with Obinutuzumab - Single Centre Experience from University Clinic of Hematology, Skopje

PRILOZI
Volume 47 (2026): Issue 1 (March 2026)
By: Olivera Gjeorgjieva Janev,  Tara Mojsovska,  Martin Stojanoski,  Marica Pavkovic,  Marija Popova Labachevska,  Lazar Chadievski,  Aleksandra Pivkova Veljanovska,  Zlate Stojanoski and  Sonja Genadieva Stavrikj  
Open Access
|Mar 2026
DOI: https://doi.org/10.2478/prilozi-2026-0010 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345
Journal RSS Feed
Language: English
Page range: 93 - 100
Published on: Mar 21, 2026
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
chronic lymphocytic leukemia,
obinutuzumab,
combination therapy
Related subjects:
Medicine,
Basic medical science,
History and ethics of medicine,
Clinical medicine,
Clinical medicine, other,
Social sciences,
Education,
Education, other

© 2026 Olivera Gjeorgjieva Janev, Tara Mojsovska, Martin Stojanoski, Marica Pavkovic, Marija Popova Labachevska, Lazar Chadievski, Aleksandra Pivkova Veljanovska, Zlate Stojanoski, Sonja Genadieva Stavrikj, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 47 (2026): Issue 1 (March 2026)Next article